Improvement of Radioimmunotherapy Using Pretargeting

During the past two decades, considerable research has been devoted to radionuclide therapy using radiolabeled monoclonal antibodies and receptor binding agents. Conventional radioimmunotherapy (RIT) is now an established and important tool in the treatment of hematologic malignancies such as Non-Ho...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Frampas, Eric, Rousseau, Caroline, Bodet-Milin, Caroline, Barbet, Jacques, Chatal, Jean-Francois, Kraeber-Bodéré, Françoise
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2013
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687199/
https://ncbi.nlm.nih.gov/pubmed/23802097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2013.00159
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars